U.S. markets open in 8 hours 54 minutes

Collegium Pharmaceutical: 4Q Earnings Snapshot

STOUGHTON, Mass. (AP) _ Collegium Pharmaceutical Inc. (COLL) on Thursday reported a fourth-quarter loss of $2.2 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Stoughton, Massachusetts-based company said it had a loss of 7 cents.

The results topped Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 17 cents per share.

The specialty pharmaceutical company posted revenue of $74.2 million in the period, which also topped Street forecasts. Six analysts surveyed by Zacks expected $73.3 million.

For the year, the company reported that its loss narrowed to $22.7 million, or 68 cents per share. Revenue was reported as $296.7 million.

Collegium Pharmaceutical shares have risen slightly more than 5% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $21.68, an increase of 50% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on COLL at https://www.zacks.com/ap/COLL